Clinical Trials Browser

Hemangiosarcoma × eribulin × Clear all

NCT03331250 2025-12-23

Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

Phase 2 Active not recruiting

13 enrolled 9 charts

Hemangiosarcoma, Hemangioendothelioma, Epithelioid